MiiHealth AI Closes $2.8M Seed to Automate Patient Intake

August 10, 2026

Fundraise Insider tracks newly funded startups each week and delivers verified sales leads of C-suite contacts straight to your inbox, so you reach the right people while the funding is still fresh. See pricing.

MiiHealth AI closed a $2.8 million seed round on August 5, 2026, led by Russell Glass, founder of Arteria Capital and previously chief executive of Headspace. A group of physician angels, healthcare operators and digital health founders also participated.

The company is based in Phoenix, Arizona, and sells an agentic AI platform that automates patient intake and clinical documentation. MiiHealth says the result gives providers back roughly two hours a day, which is the kind of number that gets a healthcare product past the pilot stage.

Kelvin Summoogum founded the company.

The capital funds expansion of the engineering and AI teams and a broader specialty protocol catalogue for DAINA, the company assistant. MiiHealth also plans to deepen clinical reasoning and safety checks, speed up integrations with major electronic health record systems, and grow its commercial and customer success teams.

You may also like

35 Sales Email Tips to Crush Your Sales Game

In today’s digital age, email remains one of the most effective tools for reaching out to potential customers and driving sales. However, crafting a successful sales email can be tricky, as you need […]

Recently Funded Startups Are A Great Sales Target. Here’s Why.

The startup industry has been growing at an unprecedented rate in recent years, with billions of dollars being poured into the sector every year. This growth has created an opportunity for businesses to […]

How to Identify Your B2B Target Audience: A Comprehensive Guide

For any business to succeed, it is essential to target the right audience. In B2B marketing, identifying your target audience is even more important, as it helps you focus your efforts and resources […]